Skip to main content
Premium Trial:

Request an Annual Quote

Data Integration from the Odd Couple

Premium

Publisher John Wiley & Sons has been selling science content since the 1870s. Informatics firm LabBook has existed since January 2000. Call it an unlikely pairing, but representatives of both companies believe their recent alliance could reshape how scientists approach their work.

The major head-scratcher in the announcement was the entry of publisher Wiley into the bioinformatics field. “[Scientists] don’t really think about us as providing the data they need in a desktop environment,” concedes Brian Crawford, vice president and publishing director for Wiley’s life and medical sciences unit. But that’s exactly what his company wants to do. The product will combine LabBook’s XML browser with Wiley’s science content (including its laboratory manual series, Current Protocols) and will also enable scientists to incorporate their own data, other licensed data, and various resources. “It’s going to be an integration platform,” Crawford explains.

“That’s why the pharma firms are expressing an interest in this,” Crawford says. “It resides at the client level. … Whatever the customer is actually licensing, LabBook can write the data filter for.”

LabBook has its own interest in the venture. The platform will be based on the company’s version of XML — and as frustrated bioinformaticists everywhere know, there’s no set language standard yet in the field. So the time is ripe for LabBook to carve out its XML niche now. “If all these entities begin to embrace our flavor of XML,” says Shawn Green, LabBook’s CEO, “we believe we will certainly emerge as the standard.” The company expects to continue building XML converters, however.

The Wiley/LabBook product will have a rolling launch starting this summer and working into the fall.

— Meredith Salisbury

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.